Hedge Fund - Vivo Capital
Aclaris Therapeutics Inc. (ACRS)
Holding History Records
| No. | Filing Period | Value | % of Portfolio | Number of Shares | Avg. Quarterly Share Price |
|---|---|---|---|---|---|
| 1 | 2025 - Q1 (2025-03-31) | $13,599,999 | 1.8% | 8,888,888 | $2.13 |
| 2 | 2024 - Q4 (2024-12-31) | $22,044,442 | 2.46% | 8,888,888 | $2.49 |
| 3 | 2023 - Q4 (2023-12-31) | $0 | 0% | 0 | $3.05 |
| 4 | 2023 - Q3 (2023-09-30) | $6,155,622 | 0.67% | 898,631 | $8.55 |
| 5 | 2023 - Q2 (2023-06-30) | $9,318,803 | 0.64% | 898,631 | $9.05 |
| 6 | 2023 - Q1 (2023-03-31) | $7,269,925 | 0.5% | 898,631 | $12.69 |
| 7 | 2022 - Q4 (2022-12-31) | $14,153 | 1.62% | 898,631 | $16.09 |
| 8 | 2022 - Q3 (2022-09-30) | $14,144,000 | 1.56% | 898,631 | $15.75 |
| 9 | 2022 - Q2 (2022-06-30) | $12,545,000 | 1.25% | 898,631 | $14.01 |
| 10 | 2022 - Q1 (2022-03-31) | $15,492,000 | 1.06% | 898,631 | $13.64 |
| 11 | 2021 - Q4 (2021-12-31) | $13,391,000 | 0.8% | 920,982 | $15.15 |
| 12 | 2021 - Q3 (2021-09-30) | $16,934,000 | 0.76% | 940,754 | $16.03 |
| 13 | 2021 - Q2 (2021-06-30) | $24,132,000 | 1.04% | 1,374,279 | $22.72 |
| 14 | 2021 - Q1 (2021-03-31) | $41,510,000 | 1.45% | 1,647,214 | $19.56 |
| 15 | 2020 - Q4 (2020-12-31) | $10,657,000 | 0.47% | 1,647,214 | $4.22 |
| 16 | 2020 - Q3 (2020-09-30) | $4,233,000 | 0.24% | 1,647,214 | $2.24 |
| 17 | 2020 - Q2 (2020-06-30) | $2,668,000 | 0.19% | 1,647,214 | $1.34 |
| 18 | 2020 - Q1 (2020-03-31) | $1,713,000 | 0.15% | 1,647,214 | $1.36 |
| 19 | 2019 - Q3 (2019-09-30) | $0 | 0% | 0 | $1.42 |
| 20 | 2019 - Q2 (2019-06-30) | $3,607,000 | 0.33% | 1,647,214 | $5.45 |
| 21 | 2019 - Q1 (2019-03-31) | $9,867,000 | 0.98% | 1,647,214 | $6.63 |
| 22 | 2018 - Q4 (2018-12-31) | $12,173,000 | 1.55% | 1,647,214 | $10.31 |
| 23 | 2018 - Q3 (2018-09-30) | $23,918,000 | 2.41% | 1,647,214 | $17.14 |
| 24 | 2018 - Q2 (2018-06-30) | $32,895,000 | 4.23% | 1,647,214 | $18.48 |
| 25 | 2018 - Q1 (2018-03-31) | $28,859,000 | 4.08% | 1,647,214 | $21.19 |
| 26 | 2017 - Q4 (2017-12-31) | $40,620,000 | 8.7% | 1,647,214 | $24.35 |
| 27 | 2017 - Q3 (2017-09-30) | $73,780,000 | 14.91% | 2,858,569 | $26.80 |
| 28 | 2017 - Q2 (2017-06-30) | $77,524,000 | 19.52% | 2,858,569 | $27.19 |
| 29 | 2017 - Q1 (2017-03-31) | $85,243,000 | 25.07% | 2,858,569 | $28.83 |
| 30 | 2016 - Q4 (2016-12-31) | $89,116,000 | 29.36% | 3,283,569 | $25.50 |
| 31 | 2016 - Q3 (2016-09-30) | $107,342,000 | 33.45% | 4,191,397 | $21.22 |
| 32 | 2016 - Q2 (2016-06-30) | $77,415,000 | 21.14% | 4,191,397 | $19.81 |
| 33 | 2016 - Q1 (2016-03-31) | $79,427,000 | 19.92% | 4,191,397 | $19.11 |
The displayed share prices are average quarterly stock market prices.